top of page

Sickle Cell Disease

Replacing abnormal cells in sickle cell disease using iPSCs.

  • 2 hours
  • 8,500 US dollars

Service Description

iPSC technology could enable the production of healthy red blood cells to potentially replace the abnormal cells in sickle cell disease. But the clinical translation of such iPSC-derived cell therapies for sickle cell disease is still an area of ongoing research.

bottom of page